therapeuticЮжно-Российский журнал терапевтической практикиSouth Russian Journal of Therapeutic Practice2712-8156РостГМУ10.21886/2712-8156-2020-1-1-33-37therapeutic-5Research ArticleОБЗОРЫREVIEWSИЗМЕНЕНИЕ ПРЕДСТАВЛЕНИЙ О ТАКТИКЕ ПРИ ОСТРОМ ВЫРАЖЕННОМ ПОВЫШЕНИИ АРТЕРИАЛЬНОГО ДАВЛЕНИЯ В ОТСУТСТВИЕ ПОРАЖЕНИЯ ОРГАНОВ-МИШЕНЕЙCHANGING PERCEPTIONS OF TACTICS IN ACUTE MARKED INCREASE IN BLOOD PRESSURE IN THE ABSENCE OF DAMAGE TO TARGET ORGANShttps://orcid.org/0000-0002-8505-1848ГиляревскийС. Р.GilyarevskyS. R.
д.м.н., профессор кафедры клинической фармакологии и терапии
Москва
Moscow
sgilarevsky@rambler.ruФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РоссииРоссияRussian Medical Academy of Continuing Postgraduate EducationRussian Federation202015052020113337Copyright © Гиляревский С.Р., 20202020Гиляревский С.Р.Gilyarevsky S.R.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.therapeutic-j.ru/jour/article/view/5артериальная гипертониягипертонический кризотсутствие поражения органов-мишенейarterial hypertensionhypertensive crisisabsence of target organ damageReferencesWilliams B., Mancia G., Spiering W., Agabiti Rosei E., Azizi M., Burnier M., et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021—3104. doi: 10.1093/eurheartj/ehy339.Williams B., Mancia G., Spiering W., Agabiti Rosei E., Azizi M., Burnier M., et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021—3104. doi: 10.1093/eurheartj/ehy339.Whelton P.K., Carey R.M., Aronow W.S., Casey D.E. Jr., Collins K.J., Dennison Himmelfarb C., et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018;138:e484—e594. doi: 10.1161/CIR.0000000000000596.Whelton P.K., Carey R.M., Aronow W.S., Casey D.E. Jr., Collins K.J., Dennison Himmelfarb C., et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018;138:e484—e594. doi: 10.1161/CIR.0000000000000596.van den Born B.J., Lip G.Y.H., Brguljan-Hitij J., Cremer A., Segura J., Morales E., et al. ESC Council on hypertension position document on the management of hypertensive emergencies. Eur Heart J Cardiovasc Pharmacother. 2019;5:37—46. doi: 10.1093/ehjcvp/pvy032.van den Born B.J., Lip G.Y.H., Brguljan-Hitij J., Cremer A., Segura J., Morales E., et al. ESC Council on hypertension position document on the management of hypertensive emergencies. Eur Heart J Cardiovasc Pharmacother. 2019;5:37—46. doi: 10.1093/ehjcvp/pvy032.Peixoto A.J. Acute Severe Hypertension. N Engl J Med. 2019;381:1843—1852. doi: 10.1056/NEJMcp1901117.Peixoto A.J. Acute Severe Hypertension. N Engl J Med. 2019;381:1843—1852. doi: 10.1056/NEJMcp1901117.Patel K.K., Young L., Howell E.H., Hu B., Rutecki G., Thomas G., et al. Characteristics and outcomes of patients presenting with hypertensive urgency in the office setting. JAMA Intern Med. 2016;176:981—988. doi: 10.1001/jamainternmed.2016.1509Patel K.K., Young L., Howell E.H., Hu B., Rutecki G., Thomas G., et al. Characteristics and outcomes of patients presenting with hypertensive urgency in the office setting. JAMA Intern Med. 2016;176:981—988. doi: 10.1001/jamainternmed.2016.1509Vlcek M., Bur A., Woisetschläger C., Herkner H., Laggner A.N., Hirschl M.M. Association between hypertensive urgencies and subsequent cardiovascular events in patients with hypertension. J Hypertens. 2008;26:657—62. doi: 10.1097/HJH.0b013e3282f4e8b6.Vlcek M., Bur A., Woisetschläger C., Herkner H., Laggner A.N., Hirschl M.M. Association between hypertensive urgencies and subsequent cardiovascular events in patients with hypertension. J Hypertens. 2008;26:657—62. doi: 10.1097/HJH.0b013e3282f4e8b6.Grassi D., O’Flaherty M., Pellizzari M., Bendersky M., Rodriguez P., Turri D., et al. Group of Investigators of the REHASE Program. Hypertensive urgencies in the emergency department: evaluating blood pressure response to rest and to antihypertensive drugs with different profiles. J Clin Hypertens (Greenwich). 2008;10:662—667. doi: 10.1111/j.1751-7176.2008.00001.x.Grassi D., O’Flaherty M., Pellizzari M., Bendersky M., Rodriguez P., Turri D., et al. Group of Investigators of the REHASE Program. Hypertensive urgencies in the emergency department: evaluating blood pressure response to rest and to antihypertensive drugs with different profiles. J Clin Hypertens (Greenwich). 2008;10:662—667. doi: 10.1111/j.1751-7176.2008.00001.x.Levy P.D., Mahn J.J., Miller J., Shelby A., Brody A., Davidson R., et al. Blood pressure treatment and outcomes in hy- pertensive patients without acute target organ damage: a retrospective cohort. Am J Emerg Med. 2015;33:1219—1224.Levy P.D., Mahn J.J., Miller J., Shelby A., Brody A., Davidson R., et al. Blood pressure treatment and outcomes in hy- pertensive patients without acute target organ damage: a retrospective cohort. Am J Emerg Med. 2015;33:1219—1224.doi: 10.1016/j.ajem.2015.05.036.doi: 10.1016/j.ajem.2015.05.036.Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA. 1967;202:1028—1034. doi: 10.1001/jama.1967.03130240070013.Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA. 1967;202:1028—1034. doi: 10.1001/jama.1967.03130240070013.Campos C.L., Herring C.T., Ali A.N., Jones D.N., Wofford J.L., Caine A.L., et al. Pharmacologic treatment of hypertensive urgency in the outpatient setting: a systematic review. J Gen Intern Med. 2018;33:539—550. doi: 10.1007/s11606-017-4277-6.Campos C.L., Herring C.T., Ali A.N., Jones D.N., Wofford J.L., Caine A.L., et al. Pharmacologic treatment of hypertensive urgency in the outpatient setting: a systematic review. J Gen Intern Med. 2018;33:539—550. doi: 10.1007/s11606-017-4277-6.Grossman E., Messerli F.H., Grodzicki T., Kowey P. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA. 1996;276:1328—1331. doi: 10.1001/jama.1996.03540160050032.Grossman E., Messerli F.H., Grodzicki T., Kowey P. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA. 1996;276:1328—1331. doi: 10.1001/jama.1996.03540160050032.American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2015;63:2227—2246. doi: 10.1111/jgs.13702.American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2015;63:2227—2246. doi: 10.1111/jgs.13702.Alshami A., Romero C., Avila A., Varon J. Management of hypertensive crises in the elderly. J Geriatr Cardiol. 2018;15(7):504–512. doi: 10.11909/j.issn.1671-5411.2018.07.007.Alshami A., Romero C., Avila A., Varon J. Management of hypertensive crises in the elderly. J Geriatr Cardiol. 2018;15(7):504–512. doi: 10.11909/j.issn.1671-5411.2018.07.007.Varon J. Treatment of acute severe hypertension: current and newer agents. Drugs. 2008;68:283—297. DOI: 10.2165/00003495-200868030-00003.Varon J. Treatment of acute severe hypertension: current and newer agents. Drugs. 2008;68:283—297. DOI: 10.2165/00003495-200868030-00003.Van Harten J., Burggraaf K., Danhof M., van Brummelen P., Breimer D.D. Negligible sublingual absorption of nifedipine. Lancet. 1987;2(8572):1363—1365. DOI: 10.1016/s0140-6736(87)91258-xVan Harten J., Burggraaf K., Danhof M., van Brummelen P., Breimer D.D. Negligible sublingual absorption of nifedipine. Lancet. 1987;2(8572):1363—1365. DOI: 10.1016/s0140-6736(87)91258-xKaya A., Tatlisu M.A., Kaplan Kaya T., Yildirimturk O., Gungor B., Karatas B., et al. Sublingual vs. Oral Captopril in Hypertensive Crisis. J Emerg Med. 2016;50:108—115. doi: 10.1016/j.jemermed.2015.07.017.Kaya A., Tatlisu M.A., Kaplan Kaya T., Yildirimturk O., Gungor B., Karatas B., et al. Sublingual vs. Oral Captopril in Hypertensive Crisis. J Emerg Med. 2016;50:108—115. doi: 10.1016/j.jemermed.2015.07.017.Saladini F., Mancusi C., Bertacchini F., Spannella F., Maloberti A., Giavarini A., et al. Diagnosis and treatment of hypertensive emergencies and urgencies among Italian emergency and intensive care departments. Results from an Italian survey: Progetto GEAR (Gestione dell’Emergenza e urgenza in ARea critica). Eur J Intern Med. 2019;pii: S0953-6205(19)30341-3. doi: 10.1016/j.ejim.2019.10.004. [Epub ahead of print].Saladini F., Mancusi C., Bertacchini F., Spannella F., Maloberti A., Giavarini A., et al. Diagnosis and treatment of hypertensive emergencies and urgencies among Italian emergency and intensive care departments. Results from an Italian survey: Progetto GEAR (Gestione dell’Emergenza e urgenza in ARea critica). Eur J Intern Med. 2019;pii: S0953-6205(19)30341-3. doi: 10.1016/j.ejim.2019.10.004. [Epub ahead of print].Komsuoglu B., Sengun B., Bayram A., Komsuoglu S.S. Treatment of hypertensive urgencies with oral nifedipine, nicardipine, and captopril. Angiology. 1991;42:447—454. DOI: 10.1177/000331979104200603Komsuoglu B., Sengun B., Bayram A., Komsuoglu S.S. Treatment of hypertensive urgencies with oral nifedipine, nicardipine, and captopril. Angiology. 1991;42:447—454. DOI: 10.1177/000331979104200603Woisetschlaeger C., Bur A., Vlcek M., Derhaschnig U., Laggner A.N., Hirschl M.M. Comparison of intravenous urapidil and oral captopril in patients with hypertensive urgencies. J Human Hypertens. 2006;20:707—709. DOI: 10.1038/sj.jhh.1002063.Woisetschlaeger C., Bur A., Vlcek M., Derhaschnig U., Laggner A.N., Hirschl M.M. Comparison of intravenous urapidil and oral captopril in patients with hypertensive urgencies. J Human Hypertens. 2006;20:707—709. DOI: 10.1038/sj.jhh.1002063.Maleki A., Sadeghi M., Zaman M., Tarrahi M.J., Nabatchi B. Nifedipine, Captopril or Sublingual Nitroglycerin, Which can Reduce Blood Pressure the Most? ARYA Atheroscler. 2011;7:102—105. PMID: 22577455Maleki A., Sadeghi M., Zaman M., Tarrahi M.J., Nabatchi B. Nifedipine, Captopril or Sublingual Nitroglycerin, Which can Reduce Blood Pressure the Most? ARYA Atheroscler. 2011;7:102—105. PMID: 22577455Sruamsiri K., Chenthanakij B., Wittayachamnankul B. Management of patients with severe hypertension in emergency department, Maharaj Nakorn Chiang Mai hospital. J Med Assoc Thaiю 2014;97:917—922. PMID: 25536708Sruamsiri K., Chenthanakij B., Wittayachamnankul B. Management of patients with severe hypertension in emergency department, Maharaj Nakorn Chiang Mai hospital. J Med Assoc Thaiю 2014;97:917—922. PMID: 25536708Sahasranam K.V., Ravindran K.N. Sublingual captopril in severe hypertension. J Assoc Phys India. 1988;36:643—644. PMID: 1439119Sahasranam K.V., Ravindran K.N. Sublingual captopril in severe hypertension. J Assoc Phys India. 1988;36:643—644. PMID: 1439119Castro del Castillo A., Rodriguez M., Gonzalez E., Rodriguez F., Estruch J. Dose-response effect of sublingual captopril in hypertensive crises. J Clin Pharmacol. 1988;28:667—670. DOI: 10.1002/j.1552-4604.1988.tb03196.xCastro del Castillo A., Rodriguez M., Gonzalez E., Rodriguez F., Estruch J. Dose-response effect of sublingual captopril in hypertensive crises. J Clin Pharmacol. 1988;28:667—670. DOI: 10.1002/j.1552-4604.1988.tb03196.xSalkic S., Brkic S., Batic-Mujanovic O., Ljuca F., Karabasic A., Mustafic S. Emergency Room Treatment of Hypertensive Crises. Medical Arch. 2015;69:302—306. doi: 10.5455/medarh.2015.69.302-306.Salkic S., Brkic S., Batic-Mujanovic O., Ljuca F., Karabasic A., Mustafic S. Emergency Room Treatment of Hypertensive Crises. Medical Arch. 2015;69:302—306. doi: 10.5455/medarh.2015.69.302-306.
The authors declare that there are no conflicts of interest present.